Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
Clinical trial NCT06465433 · RECRUITING
Trial details
- NCT number
- NCT06465433
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2027-08-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.